Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics

Cancer is one of the leading causes of death worldwide, and conventional cancer therapies such as surgery, chemotherapy, and radiotherapy do not address the underlying molecular pathologies, leading to inadequate treatment and tumor recurrence. Angiogenic factors, such as EGF, PDGF, bFGF, TGF-β, TGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Bao T., Raguraman, Prithi, Kosbar, Tamer R., Fletcher, Susan, Wilton, Steve D., Veedu, Rakesh N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307321/
https://www.ncbi.nlm.nih.gov/pubmed/30594893
http://dx.doi.org/10.1016/j.omtn.2018.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307321/
https://www.ncbi.nlm.nih.gov/pubmed/30594893
http://dx.doi.org/10.1016/j.omtn.2018.11.007

Ejemplares similares